Petros Pharmaceuticals Inc (PTPI)
0.7133
+0.04
(+5.36%)
USD |
NASDAQ |
May 03, 16:00
0.70
-0.01
(-1.86%)
Pre-Market: 20:00
Petros Pharmaceuticals Enterprise Value: -0.0096M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | -0.0096M |
| May 02, 2024 | -0.2592M |
| May 01, 2024 | -0.3967M |
| April 30, 2024 | -0.266M |
| April 29, 2024 | -0.0728M |
| April 26, 2024 | -0.5143M |
| April 25, 2024 | -0.5143M |
| April 24, 2024 | -0.5521M |
| April 23, 2024 | -0.2378M |
| April 22, 2024 | -0.4434M |
| April 19, 2024 | -0.3066M |
| April 18, 2024 | -0.1155M |
| April 17, 2024 | -0.1698M |
| April 16, 2024 | -0.0666M |
| April 15, 2024 | 0.4704M |
| April 12, 2024 | 0.8197M |
| April 11, 2024 | 1.343M |
| April 10, 2024 | 1.175M |
| April 09, 2024 | 1.350M |
| April 08, 2024 | 1.489M |
| April 05, 2024 | 1.447M |
| April 04, 2024 | 1.645M |
| April 03, 2024 | 1.480M |
| April 02, 2024 | 2.443M |
| April 01, 2024 | 4.712M |
| Date | Value |
|---|---|
| March 28, 2024 | 5.262M |
| March 27, 2024 | 5.056M |
| March 26, 2024 | 5.743M |
| March 25, 2024 | -0.2176M |
| March 22, 2024 | -0.427M |
| March 21, 2024 | -0.427M |
| March 20, 2024 | -0.6962M |
| March 19, 2024 | -0.5765M |
| March 18, 2024 | -0.5167M |
| March 15, 2024 | -0.3672M |
| March 14, 2024 | -0.7859M |
| March 13, 2024 | -0.6214M |
| March 12, 2024 | -0.4569M |
| March 11, 2024 | -0.2475M |
| March 08, 2024 | -0.0381M |
| March 07, 2024 | -0.427M |
| March 06, 2024 | -0.1278M |
| March 05, 2024 | -0.3971M |
| March 04, 2024 | -0.0381M |
| March 01, 2024 | 0.0816M |
| February 29, 2024 | 0.2311M |
| February 28, 2024 | 0.1115M |
| February 27, 2024 | 0.0516M |
| February 26, 2024 | -0.1877M |
| February 23, 2024 | 0.0217M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-7.029M
Minimum
Dec 11 2023
73.88M
Maximum
Dec 28 2021
11.29M
Average
9.044M
Median
Nov 14 2022
Enterprise Value Benchmarks
| Avalo Therapeutics Inc | 7.435M |
| Imunon Inc | -3.194M |
| iBio Inc | 16.80M |
| Oramed Pharmaceuticals Inc | -16.74M |
| Ocugen Inc | 305.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.3182M |
| Revenue (Quarterly) | -0.3643M |
| Total Expenses (Quarterly) | 4.674M |
| EPS Diluted (Quarterly) | -2.17 |
| Profit Margin (Quarterly) | -87.34% |
| Earnings Yield | -888.8% |
| Normalized Earnings Yield | -1757.81 |